All articles by Alexandra Carrera

  1. FDA approves pancreatic cancer drug Abraxane

    US-based Celgene Corporation’s chemotherapy drug Abraxane has received approval by the US Food and Drug Administration (FDA) for the treatment…
    Read More…

    9 Sep
  2. Bayer seeks EMA approval for marketing of regorafenib to treat GIST

    Bayer HealthCare has submitted an application to the European Medicines Agency (EMA) for marketing authorisation regarding the oral multi-kinase inhibitor,…
    Read More…

    8 Sep
  3. GSK cancer vaccine fails to pass a melanoma clinical trial

    An experimental drug from GlaxoSmithKline has been unsuccessful in a late-stage clinical test to treat patients with melanoma. Its MAGE3-A3…
    Read More…

    5 Sep
  4. Groundbreaking virus survey could re-focus pathogen research

    Scientists from Columbia University estimate that at least 320,000 viral infections in mammals have yet to be discovered. They believe…
    Read More…

    4 Sep
  5. Novartis’s heart failure drug shows promise

    Switzerland-based Novartis’s experimental acute heart failure (AHF) drug serelaxin (RLX030) has proved effective in clinical trials across a range of…
    Read More…

    2 Sep
  6. Roche’s injectable Herceptin formula endorsed by the EU

    Roche has won EU approval for a new injectable formula of its breast cancer drug, Herceptin, to treat the HER2-positive…
    Read More…

    1 Sep
  7. Endo Health Solutions acquires Boca Pharmacal for $225m

    US-based Endo Health Solutions Inc, a specialty pharmaceutical, has reached an agreement to purchase privately-held Boca Pharmacal for $225m to…
    Read More…

    29 Aug
  8. Strathclyde scientists create drug detection computer programme

    Researchers from the University of Strathclyde in Glasgow have designed a computer programme aimed at finding smarter drugs to treat…
    Read More…

    28 Aug
  9. Akorn Inc purchases Hi-Tech Pharmacal for $640m

    US-based generic pharmaceutical company Akorn Inc has agreed to buy its national competitor Hi-Tech Pharmacal Co Inc for $640m. Hi-Tech…
    Read More…

    27 Aug
  10. Amgen acquires Onyx Pharmaceuticals for $10.4bn

    Biotechnology firm Amgen has agreed to acquire US cancer drug producer Onyx Pharmaceuticals for about $10.4bn, offering $125 per share….
    Read More…

    26 Aug
Close
Close
Close

Go Top